Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 179,807 | 183,906 | 169,527 | 196,349 | 122,827 |
| Cost of Goods | 128,610 | 112,642 | 96,932 | 101,753 | 41,313 |
| Gross Profit | 51,197 | 71,264 | 72,595 | 94,596 | 81,514 |
| Operating Expenses | 52,705 | 48,362 | 82,341 | 48,720 | 25,413 |
| Operating Income | -898 | 23,544 | -8,814 | 46,629 | 56,414 |
| Interest Expense | 985 | 1,772 | 1,641 | 1,446 | 168 |
| Other Income | 4,125 | 3,374 | 601 | 2,395 | 6,164 |
| Pre-tax Income | 2,242 | 25,146 | -9,854 | 47,578 | 62,410 |
| Income Tax | 59 | 8,825 | 1,837 | 16,714 | 22,686 |
| Net Income Continuous | 2,183 | 16,321 | -11,691 | 30,864 | 39,724 |
| Net Income | $2,183 | $16,321 | $-11,691 | $30,864 | $39,724 |
| EPS Basic Total Ops | 0.07 | 0.51 | -0.37 | 0.97 | 1.22 |
| EPS Basic Continuous Ops | 0.07 | 0.51 | -0.37 | 0.97 | 1.22 |
| EPS Diluted Total Ops | 0.07 | 0.50 | -0.37 | 0.95 | 1.19 |
| EPS Diluted Continuous Ops | 0.07 | 0.50 | -0.37 | 0.95 | 1.19 |
| EBITDA(a) | $14,647 | $39,063 | $21,390 | $60,058 | $62,147 |